This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,070.93 firm fixed-price delivery order contract was awarded on December 10, 2024 by the Defense Logistics Agency (DLA), with a completion date of December 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen, as the prime contractor, has established Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, in support of military, veterans, and other federal healthcare programs.
Generated 3/11/25, 9:46 AM